Global Innovative Platforms Inc. (GIPL)
Global Innovative Platforms Inc. operates in the Information Technology Services industry of the Technology sector, headquartered in Sanford, FL, US. The stock last traded at $0.50, up 0.00% on the session, giving a market capitalisation of $22.8M. On trailing twelve-month figures it carries a trailing P/E of -33.33, a net margin of -361.7%. Its beta of 5.16 implies it has historically moved more than the broad market.
Global Innovative Platforms Inc. engages in the business of testing breath to detect and assist in the treatment of disease. The company develops Heartworm breath test, which includes breath collection device, to collect shallow breath samples. It also operates VOCAM Plus and FROG platform for gas chromatography, as well as operates A.I. software to provide breath and air analysis. The company was formerly known as Canning Str Corp. and changed its name to Global Innovative Platforms Inc. in September 2021. Global Innovative Platforms Inc. was incorporated in 2020 and is based in Sanford, Florida.
Global Innovative Platforms Inc. is most often compared with the following Technology names: